The 7th Annual Cannabinoid-Derived Drug Development Summit (ICDD) covers topics such as:
- Lost in Translation: Overcoming the Barriers of in-vitro & in-vivo Action of Cannabinoid- Derived Drugs to Improve Efficacy
- Cure Humans, Not Rodents: Addressing Pain Points in Cannabinoid ‘Bench to Bedside’ to Accelerate Regulatory Approval
- Before & After The Drug Development Process: Overcoming Regulatory & Legal Challenges in Cannabinoid Drug Development
- One Drug, Various Targets: Exploring Outweighing Benefits & Risks of a Plethora of Cannabinoid Disease Targets Including Pain, Cancer & Autoimmune Diseases
- UK Government to Recognize its Potential as a ‘World Leader’ by Making it Easier for Companies to Invest in R&D
- Cannabinoid Drug Development for Endometriosis/Other Target Areas: Clinical & Legal Challenges in Australia & New Zealand
The 7th Annual Cannabinoid-Derived Drug Development Summit (ICDD) might be held in Boston in Sep 2024.
